Valuation Jade Biosciences, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 21:04:26 05/08/2026 +04			5-day change	1st Jan Change
21.35 ^USD	0.00%		+10.54%	+38.63%

07-02	Jade Biosciences to Receive up to $22 Million as Part of Licensing Deal With Paragon Therapeutics	MT
06-29	Jade Biosciences, Inc.(NasdaqCM:JBIO) added to Russell Microcap Growth Benchmark Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027	2028
Market Cap ¹	709.8	1,267	-	-
Change	-	78.54%	-	-
Enterprise Value (EV) ¹	373.7	1,014	967.1	937.5
Change	-	171.3%	-4.61%	-3.05%
P/E	-4.84x	-8.21x	-8.29x	-8.33x
PBR	-	5.04x	9.62x	5.8x
PEG	-0.2x	0.4x	8.8x	17.37x
Capitalization / Revenue	-	-	-	-
EV / Revenue	-	-	-	-
EV / EBITDA	-	-5.34x	-4.93x	-4.62x
EV / EBIT	-3.29x	-5.62x	-4.93x	-4.25x
EV / FCF	-3.94x	-6.36x	-5.54x	-4.6x
FCF Yield	-25.4%	-15.7%	-18%	-21.8%
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-3.19	-2.601	-2.577	-2.564
Distribution rate	-	-	-	-
Net sales ¹	-	-	-	-
EBITDA ¹	-	-189.7	-196.2	-203
EBIT ¹	-113.5	-180.3	-196	-220.7
Net income ¹	-127.4	-173.2	-191.2	-218.4
Net Debt ¹	-336.2	-253.5	-300.3	-329.8
Reference price ²	15.43	21.35	21.35	21.35
Nbr of stocks (in thousands)	46,004	59,360	-	-
Announcement Date	06/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JADE BIOSCIENCES, INC.	-8.21x	-	-5.34x	-	1.27B
LONZA GROUP AG	32.67x	5.84x	17.38x	0.98%	48B
REVOLUTION MEDICINES, INC.	-24.15x	363.29x	-22.19x	-.--%	41.13B
IQVIA HOLDINGS INC.	29.32x	2.95x	12.73x	-.--%	37.56B
BEONE MEDICINES AG	47.98x	4.87x	31.77x	-.--%	35.91B
CELLTRION, INC.	28.27x	8.18x	20.56x	0.41%	29.86B
MEDPACE HOLDINGS, INC.	32.7x	5.35x	24.3x	-.--%	16.05B
EUROFINS SCIENTIFIC SE	22.89x	2x	8.68x	1.16%	13.76B
ICON PUBLIC LIMITED COMPANY	26.61x	1.78x	10.95x	-.--%	12.1B
Average	20.90x	49.29x	10.98x	0.32%	26.18B
Weighted average by Cap.	22.89x	67.79x	11.84x	0.32%